Core Laboratories NV (CLB, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. Core Laboratories NV is a provider of proprietary and patented reservoir description, production enhancement & reservoir management services to the oil and gas industry. The company operates in more than 50 countries. Core Laboratories NV has a market cap of $1.5 billion; its shares were traded at around $33.91 with a P/E ratio of 14.88 and P/S ratio of 2.27. The dividend yield of Core Laboratories NV stocks is 5.60%. GuruFocus has detected 4 severe warning signs with Core Laboratories NV. .
For the last quarter Core Laboratories NV reported a revenue of $156.8 million, compared with the revenue of $173.2 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $668.2 million, a decrease of 4.7% from the previous year. For the complete 30-year financial data, please go here.. For the last five years Core Laboratories NV had an average revenue decline of 7.5% a year.
The reported diluted earnings per share was $2.28 for the year, an increase of 27.4% from previous year. Over the last five years Core Laboratories NV had an average EPS decline of 14.8% a year. The Core Laboratories NV had a decent operating margin of 15.27%, compared with the operating margin of 16.82% a year before. The 10-year historical median operating margin of Core Laboratories NV is 25.53%. The profitability rank of the company is 7 (out of 10).
At the end of the fiscal year, Core Laboratories NV has the cash and cash equivalents of $11.1 million, compared with $13.1 million in the previous year. The long term debt was $369.9 million, compared with $289.8 million in the previous year. The interest coverage to the debt is 6.9. Core Laboratories NV has a financial strength rank of 4 (out of 10).
At the current stock price of $33.91, Core Laboratories NV is traded at 61.8% discount to its historical median P/S valuation band of $88.74. The P/S ratio of the stock is 2.27, while the historical median P/S ratio is 5.94. The stock lost 43.62% during the past 12 months.
Directors and Officers Recent Trades:
- President & COO Lawrence Bruno bought 3,000 shares of CLB stock on 02/03/2020 at the average price of $34.86. The price of the stock has decreased by 2.73% since.
For the complete 20-year historical financial data of CLB, click here.
